Our in vitro data show that S63845 exerts cytotoxic effects on leukemic cells, and its anti-AML efficacy is enhanced by simultaneous targeting of BCL2/BCL-XL. This evidence concerns the gene BCL2L1 and acute myeloid leukemia.